Resources

#58 Drug: Kisqali (Ribociclib Succinate)

Top prescriber in each state and DC based on Medicare Part D records.

Home / Data Tools / Part D Prescribers / Top 100 Drug Pages / Kisqali (Ribociclib Succinate)

State-Level #1 Prescriber Table

Drug ranking is based on Medicare Part D drug spending in 2024 (Q1-Q4). Prescriber ranking is based on Medicare Part D prescriber data in 2023.

Top-100 rank metric for this drug: $775,562,471.94 total spending in 2024.

State Prescriber NPI Provider Type Total Claims Total Benes Total Costs
AlabamaElquis Castillo1609890474Medical Oncology13614$1,273,912.24
AlaskaMary Stewart1245268002Hematology-Oncology15—$146,323.25
ArizonaKristina Trafelet1881163046Nurse Practitioner25—$343,390.29
ArkansasOmer Khalil1467671792Hematology-Oncology28—$485,013.86
CaliforniaBoris Bagdasarian1598758062Hematology-Oncology6511$1,136,317.26
ColoradoMichele Basche1306820022Hematology-Oncology35—$550,874.44
ConnecticutNeal Fischbach1588758718Medical Oncology32—$462,260.09
DelawareRishi Sawhney1750346698Hematology-Oncology22—$357,407.27
District of ColumbiaNatasha Jain1578981445Hematology-Oncology26—$430,509.10
FloridaNikita Shah1265417505Hematology-Oncology51—$828,258.83
GeorgiaLawrence Gynther1447295696Hematology-Oncology51—$898,896.33
HawaiiWilliam Adler1710918610Hematology-Oncology20—$312,788.81
IdahoClinton Morgan1376779413Hematology-Oncology26—$366,431.51
IllinoisMelody Cobleigh1861451122Medical Oncology52—$816,722.73
IndianaMelanie Clark1245593854Hematology-Oncology5314$736,413.57
IowaSonam Patel1306230230Hematology-Oncology32—$521,657.09
KansasQamar Khan1013003425Hematology-Oncology7411$1,161,149.99
KentuckyNicola Jabbour1740485168Hematology-Oncology40—$691,240.87
LouisianaKirtan Koticha1528279965Hematology-Oncology32—$483,869.57
MaineBrian Haney1285830554Hematology-Oncology13—$208,844.48
MarylandShweta Kurian1962645911Hematology-Oncology31—$508,411.51
MassachusettsAhmed Safa1275970501Hematology-Oncology27—$372,403.96
MichiganHaritha Reddy1952720906Hematology-Oncology48—$707,307.24
MinnesotaDomingo Perez1801865548Medical Oncology29—$446,896.05
MississippiMaroun Hayek1922072891Hematology-Oncology41—$715,142.77
MissouriAndrew Davis1417374604Medical Oncology49—$796,654.69
MontanaChad Pedersen1881857019Hematology-Oncology13—$156,122.19
NebraskaJairam Krishnamurthy1932335007Medical Oncology24—$307,507.99
NevadaXiantuo Wu1639397631Hematology-Oncology25—$437,274.65
New HampshireEric Bonnem1265426035Medical Oncology20—$347,128.96
New JerseyNan Chen1558749887Hematology-Oncology46—$655,037.75
New MexicoJaymi Mckay1740511294Nurse Practitioner31—$512,865.22
New YorkNoshir Dacosta1154300622Medical Oncology32—$443,650.12
North CarolinaArielle Heeke1881950848Hematology-Oncology40—$540,913.77
North DakotaPatanit Watanaboonyakhet1629143169Hematology-Oncology19—$284,011.26
OhioAntoine Chahine1205879491Medical Oncology69—$1,181,203.25
OklahomaWajeeha Razaq1265619530Hematology-Oncology53—$754,642.40
OregonChristina Fitzmaurice1790915528Hematology-Oncology32—$461,877.40
PennsylvaniaRanju Gupta1720170301Hematology-Oncology28—$415,324.10
Rhode IslandPlakyil Joseph1821070418Medical Oncology14—$204,168.02
South CarolinaJulia Saylors1700998317Hematology-Oncology23—$343,472.30
South DakotaVijay Rao1982725180Hematology-Oncology12—$196,722.21
TennesseeWahid Hanna1093761124Hematology-Oncology44—$555,562.69
TexasInes Sanchez-Rivera1508863408Medical Oncology61—$1,054,652.09
UtahJoseph Te1700946423Hematology-Oncology15—$263,022.05
VermontAllan Eisemann1801993811Medical Oncology14—$104,050.52
VirginiaKumar Abhishek1083827018Hematology-Oncology54—$929,641.28
WashingtonTheodore Kim1952325359Medical Oncology23—$325,640.95
West VirginiaJame Abraham1992723654Medical Oncology37—$629,027.68
WisconsinYee Chung Cheng1811948318Hematology-Oncology28—$456,983.59
Wyoming——————

Method Note

  • Top 100 drugs are ranked by Tot_Spndng from CMS Part D drug spending data. Brand + generic pair is used for ranking and matching.
  • For each state and DC, the #1 prescriber is selected by highest Tot_Drug_Cst for the same brand + generic pair, using the 2023 prescriber file.
  • If a state has no matching record, values are shown as em dash.

Related Pages

Back to Top 100 drug pages